Since IDO1's role in immune tolerance has been unveiled, piles of studies have focused on its role in cancer immunology, leading to underappreciation of the impacts of IDO1, the rate‐limiting enzyme involved in essential amino acid metabolism, on lipid and glucose metabolism. The gene discussed is IDO1; the disease is cancer.